Genetic susceptibility to the development of autoimmune disease

Clinical Science

Volumn 93, Issue 6, 1997, Pages 479-491

  Heward, Joanne ^a   Gough, Stephen C L ^b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BIRMINGHAM HEARTLANDS HOSPITAL   (United Kingdom)

Author keywords

Autoimmunity; Cytotoxic t lymphocyte associated 4 gene; Human leucocyte antigen; Inflammatory bowel disease; Insulin dependent diabetes mellitus; Juvenile chronic arthritis; Multiple sclerosis; Psoriasis; Systemic lupus erythematosus; Thyroid disease

Indexed keywords

CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; HEAT SHOCK PROTEIN; INSULIN; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MYELIN BASIC PROTEIN; T LYMPHOCYTE RECEPTOR; THYROTROPIN RECEPTOR; TUMOR NECROSIS FACTOR;

ADDISON DISEASE; ANTIGEN PRESENTATION; AUTOIMMUNITY; CHROMOSOMAL LOCALIZATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; ENTERITIS; ETIOLOGY; GENE CLUSTER; GENE FUNCTION; GENE LOCUS; GENE MAPPING; GENETIC SUSCEPTIBILITY; GENOME; GRAVES DISEASE; HASHIMOTO DISEASE; HISTOCOMPATIBILITY GENE; HLA SYSTEM; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; JUVENILE RHEUMATOID ARTHRITIS; MAJOR CLINICAL STUDY; MULTIFACTORIAL INHERITANCE; MULTIPLE SCLEROSIS; POPULATION GENETICS; PRIORITY JOURNAL; PSORIASIS; REVIEW; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0030716833     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/cs0930479     Document Type: Review

References (105)

1. Todd JA. Genetic analysis of type 1 diabetes using whole genome approaches (Review). Proc Natl Acad Sci USA 1995; 92: 8560-5.
2. Gough SCL, Saker PJ, Pritchard LE, et al. Mutation of the glucagon receptor gene and diabetes mellitus in the UK: association or founder effect. Hum Mol Genet 1995; 4: 1609-12.
3. Spielman RS, McGinnis RE, Ewens WJ. Transmission test for linkage disequilibrium: the insulin gene region and insulin-dependent diabetes mellitus (IDDM). Am J Hum Genet 1993; 52: 506-16.
4. Copeman J, Cucca F, Hearne C, et al. Linkage disequilibrium mapping of a type 1 diabetes susceptibility gene (IDDM7) to chromsome 2q31 -q33. Nature Genet 1995; 9: 80-5.
5. Bennet ST, Lucassen AM, Gough SCL, et al. Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus. Nature Genet 1995; 9: 284-92.
6. Merriman T, Twells R, Merriman M, et al. Evidence by allelic association-dependent methods for a type 1 diabetes polygene (IDDM6) on chromosome 18q21. Hum Mol Genet 1996; 6: 1003-10.
7. Davies J, Kawaguchi Y, Bennet S, et al. A genome-wide search for human type 1 diabetes susceptibility genes. Nature (London) 1994; 371: 130-6.
8. Hashimoto L, Habita C, Beressi J, et al. Genetic mapping of a susceptibility locus for insulin dependent diabetes mellitus on chromosome 11q. Nature (London) 1994; 371: 161-4.
9. Sawcer S, Jones HB, Feakes R, et al. A genome screen in multiple sclerosis reveals susceptibility loci on chromosome 6p21 and 17q22. Nature Genet 1996; 13: 464-8.
10. The Multiple Sclerosis Genetics group. A complete genome screen for multiple sclerosis underscores a role for the major histocompatibility complex. Nature Genet 1996; 13: 469-71.
11. Ebers GC, Kukay K, Bulman DE, et al. A full genome search in multiple sclerosis. Nature Genet 1996; 13: 472-6.
12. Tomfohrde J, Silverman A, Barnes R, et al. Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science (Washington DC) 1994; 264: 1141-5.
13. Matthews D, Fry L, Powles A, et al. Evidence that a locus for familial psoriasis maps to chromosome 4q. Nature Genet 1996; 14: 231-3.
14. Hugot JP, Laurent-Puig P, Gower-Rousseau C, et al. Mapping of a susceptibility locus for Crohn's disease on chromosome 16. Nature (London) 1996; 379: 821-3.
15. Payami H, Joe S, Thomson G. Autoimmune thyroid disease in type 1 diabetic families. Genet Epidemiol 1989; 7: 83-5.
16. Olmos P, A'Hern R, Heaton A, et al. The significance of the concordance rate for Type 1 (insulin-dependent) diabetes in identical twins. Diabetologia 1988; 31: 747-50.
17. Kyvik KO, Green A, Beck-Nielsen H. Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins. Br Med J 1995; 311: 913-17.
18. Gough SCL. Genetics of insulin dependent diabetes mellitus. In: Shield JPH, Baum JD, eds. Clinical paediatrics - childhood diabetes. London: Bailliere's, 1996: 593-605.
19. Cucca F, Todd JA. HLA susceptibility to type 1 diabetes: methods and mechanisms. In: Browning MJ, McMichael AJ, eds. HLA/MHC: genes, molecules and functions. Oxford, U.K.: BIOS Scientific Publishers, 1996: 383-406.
20. Colonna M. Allelic variants of the human putative peptide transporter involved in antigen processing. Proc Natl Acad Sci USA 1992; 89: 3932-6.
21. Caillat-Zucman S, Bertin E, Timsit J, Boitard C, Assan R, Bach JF. Protection from insulin-dependent diabetes mellitus is linked to a peptide transporter gene. Eur J Immunol 1993; 23: 1784-8.
22. Deng GY, Muir A, Maclaren NK, She JX. Association of LMP2 and LMP7 genes within the major histocompatibility complex with insulin dependent diabetes mellitus: population and family studies. Am J Hum Genet 1995; 56: 528-34.
23. Caillat-Zucman S, Daniel S, Timsit J, Garchon H, Boitard C, Bach J. Family study of linkage disequilibrium between TAP2 transporter and HLA class II genes: absence of TAP2 contribution to association with insulin dependent diabetes mellitus. Hum Immunol 1995; 44: 80-7.
24. Ronningen KS. Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin dependent diabetes mellitus. Eur J Immunol 1993; 23: 1050-6.
25. Undlien DE, Akselsen HE, Joner G, et al. No independent associations of LMP2 and LMP7 polymorphisms with susceptibility to develop IDDM. Diabetes 1997; 46: 307-12.
26. Bennet ST, Todd JA. Human type 1 diabetes and the insulin gene: principles of mapping polygenes. Annu Rev Genet 1996; 30: 343-70.
27. Lucassen A, Julier C, Beressi J.-P., et al. Susceptibility to insulin dependent diabetes mellitus maps to a 4.1 kb segment of DNA spanning the insulin gene and associated VNTR. Nature Genet 1993; 4: 305-10.
28. Yanagawa T, Hidaka Y, Guimaraes V, Soliman M, DeGroot LJ. CTLA4 gene polymorphism associated with Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1995; 80: 41-5.
29. Bluestone JA. Is CTLA-4 a master switch for peripheral T cell tolerance? J Immunol 1997; 128: 1989-93.
30. Walanus TL, Bakker CY, Bluestone JA. CTLA-4 ligation blocks CD-28-dependem T cell activation. J Exp Med 1996; 183: 2541-50.
31. Nistico L, Buzzetti, Pritchard LE, et al. The CTLA4 region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Hum Mol Genet 1996; 5: 1075-89.
32. Meek JC, Jones AE, Lewis UJ, Vanderlaan WP. Characterisation of the long-acting thyroid stimulator of Graves' disease. Proc Natl Acad Sci USA 1964; 52: 342-9.
33. Stenszky V, Kozma L, Balazs C, et al. The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab 1985; 61: 735-40.
34. Katsuren E, Awata T, Matsumoto C, Yamamoto K. HLA class II alleles in Japanese patients with Graves' disease: weak associations of HLA-DR and -DQ. Endocr J 1994; 41: 599-603.
35. Cavan DA, Penny MA, Jacobs KH, et al. The HLA association with Graves' disease is sex-specific in Hong Kong Chinese subjects. Clin Endocrinol 1994; 40: 63-6.
36. Yanagawa Y, Mangkabruks A, Chang YB, et al. Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab 1993; 76: 1569-74.
37. Barlow ABT, Wheatcroft N, Watson P, Weetman AP. Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women. Clin Endocrinol 1996; 44: 73-7.
38. Roman SH, Greenberg D, Rubinstein P, Wallenstein S, Davies TF. Genetics of autoimmune thyroid disease: lack of evidence for linkage to HLA within families. J Clin Endocrinol Metab 1992; 74: 496-503.
39. Shields DC, Ratanachaiyavong S, McGregor AM, Collins A, Morton NE. Combined segregation and linkage analysis of Graves' disease with a thyroid autoantibody diathesis. Am J Hum Genet 1994; 55: 540-54.
40. Ratanachaiyavong S, McGregor AM. HLA-DPB1 polymorphisms on the MHC-extended haplotypes of families of patients with Graves' disease: two distinct HLA-DR17 haplotypes. Eur J Clin Invest 1994; 24: 309-15.
41. Donner H, Rau H, Walfish PG, et al. CTLA4 alanine-17 confers genetic susceptibility to Graves' disease and to type 1 diabetes mellitus. J Clin Endocrinol Metab 1997; 82: 143-6.
42. Kotsa K, Watson PF, Weetman AP. A CTLA4 gene polymorphism is associated with both Graves' disease and autoimmune hypothyroidism. Clin Endocrinol 1997; 46: 551-4.
43. Bahn RS, Dutton CM, Heufelder AE, Sarkar G. A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab 1994; 78: 256-60.
44. Cuddihy RM, Schaid DS, Bahn RS. Multivariate analysis of HLA loci in conjunction with a thyrotropin receptor codon 52 polymorhpism in conferring risk of Graves' disease. Thyroid 1996; 6: 261-5.
45. Watson PF, French A, Pickerill AP, Mcintosh RS, Weetman AP. Lack of association between a polymorphism in the coding region of the thyrotropin receptor gene and Graves' disease. J Clin Endocrinol Metab 1995; 80: 1032-5.
46. de Roux N, Shields DC, Misrahi M, Ratanachaiyavong S, McGregor AM, Milgrom E. Analysis of the thyrotropin receptor as a candidate gene in familial Graves' disease. J Clin Endocrinol Metab 1996; 81: 3483-6.
47. Tomer Y, Barbesino G, Keddache M, Greenberg DA, Davies TF. Mapping of a major susceptibility locus for Graves' disease (GD-1) to chromosome 14q31. J Clin Endocrinol Metab 1997; 82: 1645-8.
48. Blakemore AI, Watson PF, Weetman AP, Duff GW. Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab 1995; 80: 111-15.
49. Tandon N, Zhang L, Weetman AP. HLA associations with Hashimoto's thyroiditis. Clin Endocrinol 1991; 34: 383-6.
50. Jenkins D, Penny MA, Fletcher JA, et al. HLA class II gene polymorphism contributes little to Hashimoto's thyroiditis. Clin Endocrinol 1992; 37: 141-5.
51. Wan XL, Kimura A, Dong RP, Honda K, Tamai H, Sasazuki T. HLA-A and DRB4 genes in controlling the susceptibility to Hashimoto's thyroiditis. Hum Immunol 1995; 42: 131-6.
52. Ebers GC, Bulman DE, Sadovnick AD, et al. A population-based study of multiple sclerosis in twins. N Engl J Med 1986; 315: 1638-42.
53. Sadovnick AD, Baird PA, Ward RH. Multiple sclerosis: updated risks for relatives. Am J Med Genet 1988; 29: 533-41.
54. Ebers GC, Sadovnick AD, Risch NJ, Group CCS. A genetic basis for familial aggregation in multiple sclerosis. Nature (London) 1995; 377: 150-1.
55. Robertson NP, O'Riordan JI, Chataway J, et al. Offspring recurrence rates and clinical characteristics of conjugal multiple sclerosis. Lancet 1997; 349: 1587-90.
56. Cullen CG, Middleton D, Savage DA, Hawkins S. HLA-DR and -DQ DNA genotyping in multiple sclerosis patients in Northern Ireland. Hum Immunol 1991; 30: 1-6.
57. Marrosu MG, Munoni F, Murru MR, et al. Sardinian multiple sclerosis is associated with HLA-DR4: a serologic and molecular analysis. Neurol 1988; 38: 1749-53.
58. Spurkland A, Ronnongen KS, Vandvik B, Thorsby E, Vartdal F. HLA-DQA1 and DQB1 genes may jointly determine susceptibility to develop multiple sclerosis. Hum Immunol 1991 ; 30: 69-75.
59. Haegert DG, Francis GS. HLA-DQ polymorphisms do not explain HLA class II associations with multiple sclerosis in two Canadian patient groups. Neurol 1993; 43: 1207-10.
60. Kelly MA, Zhang Y, Mijovic CH, Chou K-Y, Barnett AH, Francis DA. Genetic susceptibility to multiple sclerosis in the Shanghai Chinese is not linked to the myelin basic protein microsatellite. J Clin Pathol Mol Pathol 1995; 48: M111-2.
61. Ibsen SN, Clausen JA. A repetitive DNA sequence 5′ to the human myelin basic protein gene may be linked to MS in Danes. Acta Neurol Scand 1996; 93: 236-40.
62. Ibsen SN, Clausen JA. Genetic susceptibility to multiple sclerosis may be linked to ploymorphism of the myelin basic protein gene. J Neurol Sci 1995; 131: 96-8.
63. Murphy J, Murphy SF. Myasthenia gravis in identical twins. Neurology 1986; 36: 78-80.
64. Kerzin-Storrar L, Metcalf RA, Dyer PA, Kowalska G, Ferguson I, Harris R. Genetic factors in myasthenia gravis: a family study. Neurology 1988; 38: 38-42.
65. Fritz D, Hermann C Jr, Naeim F, Smith GS, Walford RL. HL-A antigens in myasthenia gravis. Lancet 1974; 1: 240-2.
66. Nako Y, Miyazaki T, Ota K et al. Gm allotypes in myasthenia gravis. Lancet 1980; 1: 677-80.
67. Oksenberg JR, Sherritt M, Begovitch AB, et al. T-cell receptor V alpha and C alpha alleles associated with muliple sclerosis and myasthenia gravis. Proc Natl Acad Sci USA 1989; 86: 988-91
68. Garchin HJ, Djabiri F, Viard JP, Gajdos P, Bach JF. Involvement of human muscle acetylcholine receptor α subunit gene (CHRNA) in susceptibility to myasthenia gravis. Proc Natl Acad Sci USA 1994; 91: 4668-72.
69. Heckmann JM, Morrison KE, Emeryk-Szajewska B, et al. Human muscle acetylcholine receptor alpha-subunit gene (CHRNAI) association with autoimmune myasthenia gravis in black, mixed-ancestry and Caucasian subjects. J Autoimm 1996; 9: 175-80.
70. Maclaren NK, Riley W. Inherited susceptibility to autoimmune Addison's disease linked to human leukocyte antigens DR3 and/or DR4, except when associated with type 1 autoimmune polyglandular syndrome. J Clin Endocrinol Metab 1986; 62: 455-9.
71. Weetman AP, Zhang L, Tandon N, Edwards OM. HLA associations with autoimmune Addison's disease. Tissue Antigens 1991; 38: 31-3.
72. Partanen J, Peterson P, Westman P, Aranko S, Krohn K. MHC class II and III in Addison's disease. MHC alleles do not predict autoantibody specificity and no independent role for 21-hydroxylase gene polymorphism in disease susceptibility. Hum Immunol 1994; 41: 135-40.
73. Winqvist O, Karlsson FA, Kampe O. 21-hydroxylase, a major autoantigen in idiopathic Addison's disease. Lancet 1992; 339: 1559-62.
74. Hochberg MC. The application of genetic epidemiology to systemic lupus erythematosus. J Rheumatol 1987; 14: 867-9.
75. Kaplan D. The onset of disease in twins and siblings with systemic lupus erythematosus. J Rheumatol 1984; 11: 648-52.
76. Deapen DM, Escalante A, Weinrib L, et al. A revised estimate of twin concordance in systemic lupus erythematosus. Arth Rheum 1992; 35: 311-18.
77. Hamilton RG, Harley JB, Bias WB, et al. Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus: correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. Arth Rheum 1988; 31: 496-505.
78. Harley JB, Alexander EL, Arnett FC, et al. Anti-Ro/SSA and anti-La/SSB in patients with Sjogrens syndrome. Arth Rheum 1986; 29: 196-206.
79. Harley JB, Reichlin M, Arnett FC, et al. Gene interactions at HLA-DQ enhances autoantibody production in primary Sjogrens syndrome. Science (Washington DC) 1986; 232: 1145-7.
80. Savi M, Ferraccioli GF, Neri TM, et al. HLA-DR antigens and anticardiolipin antibodies in Northern Italian systemic lupus erythematosus patients. Arth Rheum 1988; 31: 1568-70.
81. Skarsvag S, Hansen KE, Holst A, Moen T. Distribution of HLA class II alleles among Scandanavian patients with systemic lupus erythematosus (SLE): an increased risk of SLE among non [DRB1*03, DQA180501, DQB180201] class II homozygotes? Tissue Antigens 1992; 40: 128-33.
82. Doherty DG, Ireland R, Demaine AG, et al. Major histocompatibility complex genes and susceptibility to systemic lupus erythematosus in Southern Chinese. Arth Rheum 1992; 35: 641-5.
83. Yao Z, Kimura A, Hartung K, et al. Polymorphism of the DQA1 promotor region (QAP) and DRB1, QAP, DQA1, DQB1 haplotypes in systemic lupus erythematosus. Eur J Immunogenet 1993; 20: 259-66.
84. Jarjour W, Reed AM, Gauthier J, Hunt S, Winfield JB. The 8.5-kb Pstl allele of the stress protein gene, Hsp 70-2. An independent risk factor for systemic lupus erythematosus in African Americans. Hum Immunol 1996; 45: 59-63.
85. Wilson AG, Gordon C, di Giovine FS, et al. A genetic association between systemic lupus erythematosus and tumour necrosis factor alpha. Eur J Immunol 1994; 24: 191-5.
86. Hasstedt SJ, Clegg DO, Ingles L, Ward RH. HLA-linked rheumatoid arthritis. Am J Hum Genet 1994; 55: 738-46.
87. MacGregor A, Ollier W, Thomson W, Jawaheer D, Silman A. HLA-DRB1*0401/ 0404 genotype and rheumatoid arthritis: increased association in men, young age at onset, and disease severity. J Rheumatol 1995; 22: 1032-6.
88. Suarez- Almazoe ME, Tao S, Moustarah F, Russell AS, Maksymowych W. HLA-DR1, DR4, and DRB1 disease related subtypes in rheumatoid athritis. Association with susceptibility but not severity in a city wide community based study. J Rheumatol 1995; 22: 2027-33.
89. Hall FC, Weeks DE, Camilleri JP, et al. Influence of the HLA-DRB1 locus on susceptibility and severity in rheumatoid arthritis. Q J Med 1996; 89: 821-9.
90. Mu H, Charmley P, King MC, Criswell LA. Synergy between T cell receptor beta gene polymorphism and HLA-DR4 in susceptibility to rheumatoid arthritis. Arth Rheum 1996; 39: 931-7.
91. Shaw MA, Clayton D, Atkinson SE, et al. Linkage of rheumatoid arthritis to the candidate gene NRAMP1 on 2q35. J Med Genet 1996; 33: 672-77.
92. Hardwick LJ, Walsh S, Butcher S, et al. Genetic mapping of susceptibility loci in the genes involved in rheumatoid arthritis. J Rheumatol 1997; 24: 197-8.
93. Satsangi J, Welsh KI, Bunce M, et al. Contribution of genes of the major histocompatibility complex to susceptibility and disease phenotype in inflammatory bowel disease. Lancet 1996; 347: 1212-17.
94. Heresbach D, Colombel F, Danze PM, Semana G. The HLA DRB1*0301-DQB1*0201 haplotype confers protection against inflammatory bowel disease. Am J Genet 1996; 91: 1060.
95. Ohmen JD, Yang HY, Yamamoto KK, et al. Susceptibility locus for inflammatory bowel disease on chromosome 16 has a role in Crohn's disease but not in ulcerative colitis. Hum Mol Genet 1996; 5: 1679-83.
96. Swanbeck G, Inerot A, Martinsson T, Wahlstrom J. A population genetic study of psoriasis. Br J Dermatol 1994; 131: 32-9.
97. Schmitt-Egenolf M, Eiermann TH, Boehncke WH, Stander M, Sterry W. Familial juvenile onset psoriasis is associated with the human leukocyte antigen (HLA) class I side of the extended haplotype Cw6-B57-DRB1*0701-DQA1*0201-DQB1*0303: a population and family based study. J Invest Dermatol 1996; 106: 711-14.
98. Matthews D, Fry L, Powles A, Weissenbach J, Williamson R. Confirmation of genetic heterogeneity in familial psoriasis. J Med Genet 1995; 32: 546-8.
99. Nair Rp, Guo SW, Jenisch S, et al. Scanning chromosome 17 for psoriasis susceptibility: lack of evidence for a distal 17q locus. Hum Hered 1995; 45: 219-30.
100. Trembath RC, Clough RL, Rosbotham JL, et al. Identification of a major locus on chromosome 6p and evidence for further disease loci revealed by a two stage genome-wide search in psoriasis. Hum Mol Genet 1997; 6: 813-20.
101. Ploski R, Vinje O, Ronningen KS, et al. HLA class II alleles and heterogeneity of juvenile rheumatoid arthritis. Arth Rheum 1993; 36: 465-71.
102. Paul C, Schoenwald U, Truckenbrodt H, et al. HLA-DP/DR interaction in early onset pauciarticular juvenile chronic arthritis. Immunogenetics 1993; 37: 442-8.
103. Barron KS, Silverman ED, Gonzales JC, Owerbach D, Reveille JD. DNA analysis of HLA-DR, DQ and DP alleles in children with polyarticular juvenile rheumatoid arthritis. J Rheumatol 1992; 19: 1611-15.
104. Luyrink L, Gabriel CA, Thompson SD, et al. Reduced expression of a human Vβ 6.1 T cell receptor allele. Proc Natl Acad Sci USA 1993; 90: 4369-73.
105. McDowell TL, Symonds JA, Ploski R, Forre O, Duff G. A genetic association between juvenile rheumatoid arthritis (JRA) and interleukin 1 alpha (IL1α) polymorphism. Arth Rheum 1995; 38: 221-8.